Careers

Lilly is in the early phase of an exciting period of growth for the company, as our scientists work to expand our portfolio of innovative medicines to offer new treatment options for patients in the areas of diabetes, oncology, immunology, and neuroscience.

David A. Ricks, Lilly’s chairman and CEO